{{Short description|Broad-antigen serotype}} frame|right|Illustration of HLA-DR '''HLA-DR5''' (DR5) is a broad-antigen serotype that is further split into HLA-DR11 and HLA-DR12 antigen serotypes.
==Serology== {| border="0" cellspacing="0" cellpadding="0" align="left" style="text-align:center; background:#ffffff; margin-right: 1em; border:2px #e0e0ff solid;" |+ DR11, DR5 and DR12 recognition of the gene products of some DRB1*11 and DRB1*12 alleles<ref>[http://www.ebi.ac.uk/imgt/hla/allele.html derived from IMGT/HLA]</ref> |- style="background:#f0f0ff" | style="width:60px" | DRB1* || style="width:60px" | '''DR11''' | style="width:60px" | DR5 || style="width:60px" | DR12 || style="width:60px" | Sample |- style="background:#f0f0ff" | allele || % || % || % || size (N) |- | style = "background:#e8e8f8" | 11:01 || 92 || 5 || || 3474 |- | style = "background:#e8e8f8" | 11:02 || 89 || 3 || || 430 |- | style = "background:#e8e8f8" | 11:03 || 89 || 4 || || 397 |- | style = "background:#e8e8f8" | 11:04 || 87 || 4 || || 2119 |- | style = "background:#e8e8f8" | 11:05 || 75 || || || 4 |- | style = "background:#e8e8f8" | 11:06 || 20 || 73 || || 15 |- | style = "background:#e8e8f8" | 11:07 || >50 || || || 1 |- | style = "background:#e8e8f8" | 11:08 || >50 || || || 2 |- | style = "background:#e8e8f8" | 11:09 || 80 || 20 || || 5 |- | style = "background:#e8e8f8" | || || || || . |- style="background:#f0f0ff" | style="width:60px" | || style="width:60px" | '''DR12''' | style="width:60px" | DR5 || style="width:60px" | DR11 || style="width:60px" | Sample |- | style = "background:#e8e8f8" | 12:01 || 83 || 4 || 2 || 893 <ref>DR8 - 2%</ref> |- | style = "background:#e8e8f8" | 12:02 || 89 || || || 162 |- | style = "background:#e8e8f8" | 12:03 || >50 || || || 3 |- | style = "background:#e8e8f8" | 12:06 || >50 || || || 2 |- |}
Except for a few DRB1* alleles, the reactivity of DR5 is relatively poor.
==Disease associations== DR5 is associated with persistent generalized lymphadenopathy<ref>{{cite journal | doi = 10.1111/j.1399-0039.1987.tb01550.x |vauthors=Raffoux C, David V, Couderc L, Rabian C, Clauvel J, Seligmann M, Colombani J | title = HLA-A, B and DR antigen frequencies in patients with AIDS-related persistent generalized lymphadenopathy (PGL) and thrombocytopenia. | journal = Tissue Antigens | volume = 29 | issue = 1 | pages = 60–2 | year = 1987 | pmid = 3495904}}</ref> and Kaposi's sarcoma in AIDS,<ref>{{cite journal | doi = 10.1111/j.1399-0039.1983.tb00364.x |vauthors=Pollack M, Safai B, Myskowski P, Gold J, Pandey J, Dupont B | title = Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma. | journal = Tissue Antigens | volume = 21 | issue = 1 | pages = 1–8 | year = 1983 | pmid = 6601312}}</ref> juvenile rheumatoid arthritis,<ref>{{cite journal |vauthors=Førre O, Dobloug J, Høyeraal H, Thorsby E | title = HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. | journal = Arthritis Rheum | volume = 26 | issue = 1 | pages = 35–8 | year = 1983 | pmid = 6401993 | doi=10.1002/art.1780260106}}</ref><ref>{{cite journal |vauthors=Suciu-Foca N, Jacobs J, Godfrey M, Woodward K, Khan R, Reed E, Rohowsky C | title = HLA-DR5 in juvenile rheumatoid arthritis confined to few joints. | journal = Lancet | volume = 2 | issue = 8184 | pages = 40 | year = 1980 | pmid = 6104257 | doi=10.1016/S0140-6736(80)92920-7| s2cid = 40329624 }}</ref> pernicious anemia, Hashimoto's thyroiditis,<ref>{{cite journal | doi = 10.1111/j.1399-0039.1981.tb00700.x |vauthors=Farid N, Sampson L, Moens H, Barnard J | title = The association of goitrous autoimmune thyroiditis with HLA-DR5. | journal = Tissue Antigens | volume = 17 | issue = 3 | pages = 265–8 | year = 1981 | pmid = 6947505}}</ref><ref>{{cite journal |vauthors=Schleusener H, Schernthaner G, Mayr W, Kotulla P, Bogner U, Finke R, Meinhold H, Koppenhagen K, Wenzel K | title = HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter. | journal = J Clin Endocrinol Metab | volume = 56 | issue = 4 | pages = 781–5 | year = 1983 | pmid = 6131902 | doi = 10.1210/jcem-56-4-781}}</ref> mycosis fungoides,<ref>{{cite journal |vauthors=Safai B, Myskowski P, Dupont B, Pollack M | title = Association of HLA-DR5 with mycosis fungoides. | journal = J Invest Dermatol | volume = 80 | issue = 5 | pages = 395–7 | year = 1983 | pmid = 6601679 | doi = 10.1111/1523-1747.ep12553615| doi-access = free }}</ref> polyglandular deficiency syndrome,<ref>{{cite journal |vauthors=Shapiro M, Zamir R, Weiss E, Radnay J, Shenkman L | title = The polyglandular deficiency syndrome: a new variant in Persian Jews. | journal = J Endocrinol Invest | volume = 10 | issue = 1 | pages = 1–7 | year = 1987 | pmid = 3496374 | doi=10.1007/bf03347139| s2cid = 33773103 }}</ref> systemic sclerosis,<ref>{{cite journal |vauthors=Pereira S, Black C, Welsh K, Ansell B, Jayson M, Maddison P, Rowell N | title = Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families. | journal = J Rheumatol | volume = 14 | issue = 4 | pages = 760–5 | year = 1987 | pmid = 3499513}}</ref><ref>{{cite journal |vauthors=Luderschmidt C, Scholz S, Mehlhaff E, König G, Albert E | title = Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles. | journal = Arch Dermatol | volume = 123 | issue = 9 | pages = 1188–91 | year = 1987 | pmid = 3498440 | doi = 10.1001/archderm.123.9.1188}}</ref> childhood epilepsy,<ref>{{cite journal |vauthors=Minev M, Martinova F, Belopitova L | title = On the association of the HLA system with epilepsy in children. | journal = Epilepsia | volume = 28 | issue = 1 | pages = 74–6 | year = 1987| pmid = 3098558 | doi = 10.1111/j.1528-1157.1987.tb03626.x| s2cid = 12471018 }}</ref> early-onset alopecia areata,<ref>{{cite journal |vauthors=Orecchia G, Belvedere M, Martinetti M, Capelli E, Rabbiosi G | title = Human leukocyte antigen region involvement in the genetic predisposition to alopecia areata. | journal = Dermatologica | volume = 175 | issue = 1 | pages = 10–4 | year = 1987 | pmid = 3497062 | doi = 10.1159/000248775}}</ref> short-ragweed Ra6 allergy,<ref>{{cite journal |vauthors=Marsh D, Freidhoff L, Ehrlich-Kautzky E, Bias W, Roebber M | title = Immune responsiveness to Ambrosia artemisiifolia (short ragweed) pollen allergen Amb a VI (Ra6) is associated with HLA-DR5 in allergic humans. | journal = Immunogenetics | volume = 26 | issue = 4–5 | pages = 230–6 | year = 1987 | pmid = 3498688 | doi = 10.1007/BF00346517| s2cid = 25679118 | doi-access = free }}</ref> primary antiphospholipid syndrome,<ref>{{cite journal |vauthors=Vargas-Alarcon G, Granados J, Bekker C, Alcocer-Varela J, Alarcón-Segovia D | title = Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients | journal = Arthritis Rheum | volume = 38 | issue = 9 | pages = 1340–1 | year = 1995 | pmid = 7575732 | doi = 10.1002/art.1780380925| doi-access = free }}</ref> and increased longevity in the Dutch.<ref>{{cite journal |vauthors=Lagaay A, D'Amaro J, Ligthart G, Schreuder G, van Rood J, Hijmans W | title = Longevity and heredity in humans. Association with the human leucocyte antigen phenotype | journal = Ann N Y Acad Sci | volume = 621 | pages = 78–89 | year = 1991| pmid = 1859103 | doi=10.1111/j.1749-6632.1991.tb16970.x| s2cid = 83560622 }}</ref>
==Genetic linkage== HLA-DR5 reactive gene products are linked to serology of HLA-DRB3 (HLA-DR52).
==References== {{Reflist}} {{DR serotypes}}
5